Our nano immuno-engager platform can harness a patient's own immune system against cancer, while our HER2+ platform will offer a new treatment paradigm for treating HER2+ tumors.
T-NanoBio Therapeutics innovative approach has the potential to create life-changing therapies for cancer patients.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.